Innovative Drugs for the 21st Century
We are a biopharmaceutical company developing therapeutic products principally based on third generation NeuGene® antisense technology. Our principle products in development target life-threatening diseases, including cardiovascular and infectious diseases.
NeuGene drugs are synthetic polymers that block the function of selected genetic sequences involved in disease processes. Targeting specific genetic sequences provides for greater selectivity than that available through conventional drugs. We believe that NeuGene drugs have the potential to provide safe and effective treatment for a wide range of human diseases. NeuGene drugs are distinguished by a novel chemistry that replaces the modified backbones of competing technologies with a synthetic backbone designed to improve pharmaceutical parameters.